Anthony Oliva


Anthony Oliva, Ph.D. is the senior scientist and principal investigator at Longeveron LLC, an academic spin-off company engaged in pioneering regenerative medicine approaches for treating aging-related indications.  Dr. Oliva earned his undergraduate degree in Biological Sciences from the University of Chicago, and his Ph.D. in Neuroscience from Baylor College of Medicine where he developed novel animal models to study mechanism underlying neuronal injury.  Dr. Oliva continued his research as a post-doctoral fellow at the Oregon Health and Science University, studying biochemical mechanisms underlying neuronal differentiation and repair.  He went on to became an assistant scientist at The Miami Project to Cure Paralysis, and director of the Viral Vector Core Facility at the University of Miami Miller School of Medicine, where he continued his studies on biochemical mechanisms involved neuronal developed, and in traumatic brain injury.  He then became an assistant professor at the newly formed Herbert Wertheim College of Medicine at Florida International University, where he co-develop the neurology curriculum among other endeavors.  In 2015, Dr. Oliva joined Longeveron as the newly-formed company’s senior scientist, leading its clinical programs for using stem cell therapy to treat Alzheimer’s disease, Aging Frailty, and other indications.  He is the principal investigator numerous company-awarded grants, including grants from the Alzheimer’s Association, Maryland Stem Cell Research Fund TECDO, and the National Institute of Aging/National Institutes of Health (US).